KONINKLIJKE PHILIPS (PHG) Stock: Buy, Sell, or Hold?
PHG - KONINKLIJKE PHILIPS N.V.
$26.85
0.62 (2.36%)
▲
5d:
+5.34%
30d:
+9.82%
90d:
+2.6%
WAIT
LOW Confidence
Analysis Updated: Oct 22, 2026 12:00 AM ET
Earnings: Nov 03, 2026
11d
Get Alerted When PHG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PHG shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PHG shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.80
Based on 6.2% avg growth
INTRINSIC VALUE TODAY
$22.23
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PHG is currently trading at $26.85, which is considered extended relative to its 30-day fair value range of $24.17 to $25.56. The stock's valuation (Forward PE: 13.8) is in line with its historical norms (14.0). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This pessimistic expectation contrasts with the company's recent 61.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PHG is in a downtrend. The price is approaching resistance at $26.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PHG scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.02 (+22.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PHG is in a downtrend. The price is approaching resistance at $26.89. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PHG scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $32.02 (+22.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.17 -
$25.56
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
23.8%
Protect Your Profits
PHG is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+5.0% above its trading range)
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 22.1% below Wall St target ($32.02)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$24.17 -
$25.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.89
Resistance Level
$26.90
Current Trend
Downtrend
Technical data as of
Oct 22, 2026
Fundamental Context
Forward P/E (Next Year Est.)
13.85
Wall Street Target
$32.02
(+22.1%)
Revenue Growth (YoY)
0.5%
Earnings Growth (YoY)
61.4%
Profit Margin
6.3%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
13.9 vs 14.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$26.15
(0%)
2-Year Target
$26.07
(-1%)
3-Year Target
$25.99
(-1%)
3-Yr Target (if PE normalizes)
(PE: 14→14)
$26.27
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 8.4%)
$47.86
(+83%)
Base:
(SPY PE: 13.9, Growth: 8.4%)
$33.38
(+27%)
Bear:
(PE: 11.8, Growth: 8.4%)
$28.37
(+8%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (19x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 19.40 | Current EPS (TTM): $1.34
Bull Case
$40.42
(+54%)
Analyst growth 41.3%, PE expands to 21.3
Base Case
$36.74
(+40%)
Market implied 41.3%, PE stable at 19.4
Bear Case
$17.68
(-33%)
Severe decline -20.0%, PE contracts to 16.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 13.9 to 14.0
Stabilization Target:
$26.51
(+1.1%)
PE Expansion Potential:
+1.1%
Share & Embed Analysis
Last updated: October 22, 2026 3:30 PM ET
Data refreshes hourly during market hours. Next update: 4:30 PM
Data refreshes hourly during market hours. Next update: 4:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PHG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 49 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 50 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
29 analysts |
$102 | 51 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 44 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 73 BUY |
Advanced PHG Option Strategies
Professional options setups generated by AI based on today's PHG price and gamma walls.
